{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:10:25Z","timestamp":1790946625760,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.bcp.2024.116385","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T16:08:09Z","timestamp":1718986089000},"page":"116385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Androgen deprivation-induced senescence confers sensitivity to a senolytic strategy in prostate cancer"],"prefix":"10.1016","volume":"226","author":[{"given":"Valerie","family":"Carpenter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tareq","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eesha","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So","family":"Min Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Souers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony C.","family":"Faber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0437-4934","authenticated-orcid":false,"given":"David A.","family":"Gewirtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bcp.2024.116385_b0005","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1038\/s41418-020-0564-6","article-title":"BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response in TP53 wild-type breast cancer","volume":"27","author":"Shahbandi","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2024.116385_b0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-019-1607-3","article-title":"Inducing and exploiting vulnerabilities for the treatment of liver cancer","author":"Wang","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2024.116385_b0015","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1038\/s41467-022-29824-1","article-title":"Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancer","volume":"13","author":"Troiani","year":"2022","journal-title":"Nat. Commun."},{"issue":"187","key":"10.1016\/j.bcp.2024.116385_b0020","article-title":"Combination of palbociclib with navitoclax based-therapies enhances in vivo antitumoral activity in triple-negative breast cancer","volume":"1","author":"Estepa-Fern\u00e1ndez","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"10","key":"10.1016\/j.bcp.2024.116385_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1878-0261.12761","article-title":"Clearance of therapy-induced senescent tumor cells by the senolytic ABT-263 via interference with BCL-X L -BAX Interaction","volume":"14","author":"Saleh","year":"2020","journal-title":"Mol. Oncol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116385_b0030","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1124\/molpharm.121.000354","article-title":"Senolytic-mediated elimination of head and neck tumor cells induced into senescence by cisplatin","volume":"101","author":"Ahmadinejad","year":"2022","journal-title":"Mol. Pharmacol."},{"issue":"193","key":"10.1016\/j.bcp.2024.116385_b0035","article-title":"Androgen-deprivation induced senescence in prostate cancer cells is permissive for the development of castration-resistance but susceptible to senolytic therapy","volume":"1","author":"Carpenter","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116385_b0040","article-title":"Senescence and castration resistance in prostate cancer: A review of experimental evidence and clinical implications","volume":"1874","author":"Carpenter","year":"2020","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.bcp.2024.116385_b0045","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13578-020-00422-2","article-title":"Senolytic compounds control a distinct fate of androgen receptor agonist- and antagonist-induced cellular senescent LNCaP prostate cancer cells","volume":"25","author":"Pungsrinont","year":"2020","journal-title":"Cell Biosci."},{"key":"10.1016\/j.bcp.2024.116385_b0050","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bcp.2018.12.013","article-title":"Tumor cell escape from therapy-induced senescence","volume":"162","author":"Saleh","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2024.116385_b0055","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.3390\/cells9071593","article-title":"DNA damage- but not enzalutamide-induced senescence in prostate cancer promotes senolytic bcl-xl inhibitor sensitivity","volume":"9","author":"Malaquin","year":"2020","journal-title":"Cells."},{"key":"10.1016\/j.bcp.2024.116385_b0060","doi-asserted-by":"crossref","unstructured":"L. Beltzig, M. Christmann, B. Kaina. Abrogation of cellular senescence induced by temozolomide in glioblastoma cells: search for senolytics. Cells [Internet]. 2022 Aug 1 [cited 2024 May 29];11(16). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36010664.","DOI":"10.3390\/cells11162588"},{"issue":"24","key":"10.1016\/j.bcp.2024.116385_b0065","doi-asserted-by":"crossref","first-page":"13233","DOI":"10.3390\/ijms222413233","article-title":"Effects and related mechanisms of the senolytic agent ABT-263 on the survival of irradiated A549 and Ca9-22 cancer cells","volume":"22","author":"Sato","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2024.116385_b0070","doi-asserted-by":"crossref","DOI":"10.1093\/noajnl\/vdab148","article-title":"Gemcitabine radiosensitization primes irradiated malignant meningioma cells for senolytic elimination by navitoclax","volume":"3","author":"Yamamoto","year":"2021","journal-title":"Neuro-Oncology Adv."},{"issue":"7","key":"10.1016\/j.bcp.2024.116385_b0075","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41419-021-03971-7","article-title":"Bcl-2\/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy","volume":"12","author":"Ritter","year":"2021","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.bcp.2024.116385_b0080","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/pros.21465","article-title":"Development of a castrate resistant transplant tumor model of prostate cancer","volume":"72","author":"Ellis","year":"2012","journal-title":"Prostate"},{"issue":"12","key":"10.1016\/j.bcp.2024.116385_b0085","article-title":"Modeling human prostate cancer metastasis in mice via resection of subcutaneous allografts","volume":"27","author":"Peiffer","year":"2022","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.bcp.2024.116385_b0090","doi-asserted-by":"crossref","first-page":"6105","DOI":"10.18632\/oncotarget.3368","article-title":"Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy","volume":"6","author":"Santer","year":"2015","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.bcp.2024.116385_b0095","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/pros.23843","article-title":"Targeting prosurvival BCL2 signaling through Akt blockade sensitizes castration-resistant prostate cancer cells to enzalutamide","volume":"79","author":"Pilling","year":"2019","journal-title":"Prostate"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522400368X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522400368X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:11:34Z","timestamp":1728346294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522400368X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":19,"alternative-id":["S000629522400368X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116385","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Androgen deprivation-induced senescence confers sensitivity to a senolytic strategy in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114765","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116385"}}